Repairing full-thickness macular holes without using gas (no endotamponade)
Official title: The No Endotamponade for Macular Hole Repair (NEMAR) Study: An International Multi-center Randomized Controlled Trial Comparing Macular Hole Closure Using Internal Limiting Membrane Flap Without Endotamponade Versus Conventional Surgery
Run by Chinese University of Hong Kong · NCT06908824 · Data updated 2026-11-12
This trial sees if an internal limiting membrane (ILM) flap technique that omits gas can close full-thickness macular holes in adults as safely and effectively as the usual vitrectomy with gas tamponade.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 3 sites (Hong Kong and 2 other locations) |
| Status | Recruiting |
| Started | September 16, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 30, 2025 |
| Trial ID | NCT06908824 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with an OCT-confirmed full-thickness macular hole, visual acuity between approximately 0.05 and 0.8, no prior macular surgery, and without other significant macular disease or extreme myopia are ideal candidates.
✕Probably not a fit
Patients with very large holes (minimum linear diameter ≥800 µm), prior macular surgery, other central maculopathies, uncontrolled glaucoma, marked myopic chorioretinal atrophy, or pregnancy are unlikely to benefit or are excluded from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, international, randomized controlled trial comparing two surgical approaches for full-thickness macular hole repair. One arm receives conventional pars plana vitrectomy with ILM peeling and intraocular gas tamponade plus face-down posturing, while the other arm receives an ILM flap technique with no gas and no posturing restriction. Adults with OCT-confirmed full-thickness macular holes who meet size and ocular health criteria are randomized and followed for anatomical closure and safety outcomes. The trial is conducted at multiple centers in Hong Kong, Poland, and Taiwan to capture diverse patient populations and surgical practice patterns.
Why it matters
Potential benefit: If successful, the no-gas technique could achieve comparable hole closure while sparing patients early postoperative vision impairment, face-down positioning, air-travel restrictions, and exposure to ophthalmic greenhouse gases.
How similar studies have gone: Retrospective case series and early reports have shown encouraging results for ILM flap techniques without gas, but randomized controlled data directly comparing no-gas versus conventional gas tamponade are not yet published.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>= 18 years * Presence of full thickness macular hole in one eye (defined as full thickness discontinuity of neuro-sensory retina at the macula on optical coherence tomography) * Able to comply to post-operative posture * VA ≥0.05 and ≤0.8 Exclusion Criteria: * Fellow eye enrolled in the study * Eyes that underwent previous macular surgery * Presence of maculopathy other than macular hole, epi-retinal membrane or myopic maculopathy. For example, age-related macular degeneration, diabetic macular edema or pre-existing macular scar * Axial length \>/= 28mm or presence of significant myopic chorio-retinal atrophy involving the fovea * Minimum linear diameter \>/=800µm * Presence of contraindications to intraocular gas, such as advanced glaucoma or uncontrolled glaucoma * Significant macular puckering (Govetto staging ≥ stage 2) * Patients who are unable to give informed consent * Patients who are pregnant
Where it's running
-
Hong Kong Eye Hospital
Hong Kong, Hong Kong Recruiting -
Poznan University of Medical Sicences, University Hospital in Poznan
Poznan, Poland Not yet recruiting -
Chang Gung Memorial Hospital
Taoyuan, Taiwan Not yet recruiting
Study contacts
- Principal investigator: Simon KH Szeto, MBChB, FRCOphth — Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
- Study coordinator: Simon KH Dr Szeto, MBChB, MSc, FRCOphth
- Email: simonkhszeto@cuhk.edu.hk
- Phone: 852 39435886
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Closure of a macular hole with Tenon capsule graft versus ILM flap
This pilot study tests whether using a piece of the patient’s Tenon capsule can help close a macular hole as well as or better than the standard ILM flap technique.
-
Autologous Tenon's capsule graft for stubborn macular holes
This study will try using a patient's own Tenon's capsule tissue to close stubborn full-thickness macular holes and follow vision and retinal imaging for three months.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
Ultrasound-guided microwave ablation for benign thyroid nodules
This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.
-
Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia
This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.
-
Metomidate PET-CT vs Usual Care for Primary Aldosteronism
This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.